MR编号 | NL/H/3836/001 |
---|
药品名称 | Anidulafungin Teva |
---|
活性成分 | |
---|
剂型 | Powder for concentrate for solution for infusion |
---|
上市许可持有人 | Teva Nederland B.V.,
Swensweg 5
2031 GA, Haarlem,
The Netherlands |
---|
参考成员国 - 产品名称 | Netherlands (NL) Anidulafungine Teva 100 mg, poeder voor concentraat voor oplossing voor intraveneuze infusie |
---|
互认成员国 - 产品名称 | - Germany (DE)
Anidulafungin-ratiopharm 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
Anidulafungin ratiopharm 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung - Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Hungary (HU)
ANIDULAFUNGIN-TEVA 100 mg por oldatos infúzióhoz való koncentrátumhoz - Czechia (CZ)
Anidulafungin Teva - Romania (RO)
- Slovenia (SI)
- Croatia (HR)
Anidulafungin Pliva 100 mg prašak za koncentrat za otopinu za infuziju
|
---|
许可日期 | 2018/01/17 |
---|
最近更新日期 | 2024/12/02 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|